The lung cancer field continues to experience tremendous growth in precision medicine. Oncologists have more tools to treat lung cancer, but access and language remains a big factor in biomarker testing. Drs. Jessica Bauman and Lyudmila Bazhenova discuss current issues in NSCLC biomarker testing, insights on how providers can explain biomarker testing to their patients and their families, and how academic centers and community physicians can work together to overcome challenges in biomarker testing.

About the Guests:
Dr. Jessica Bauman is an Associate Professor in the Department of Hematology/Oncology at Fox Chase Cancer Center.

Dr. Lyudmila Bazhenova is a Professor of Medicine at Moores Cancer Center, UC San Diego Health.

See More from Lung Cancer | Empowering Providers to Empower Patients.